EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,199,224 | -32.6% | 135,200 | -7.0% | 0.13% | +48.2% |
| Q3 2022 | $1,780,000 | -11.5% | 145,400 | -14.5% | 0.08% | -5.6% |
| Q2 2022 | $2,011,000 | -37.8% | 170,000 | 0.0% | 0.09% | -24.4% |
| Q1 2022 | $3,233,000 | -32.3% | 170,000 | -5.6% | 0.12% | -29.6% |
| Q4 2021 | $4,779,000 | -35.4% | 180,000 | 0.0% | 0.17% | -41.5% |
| Q3 2021 | $7,394,000 | -23.2% | 180,000 | +5.9% | 0.29% | -20.4% |
| Q2 2021 | $9,629,000 | +73.7% | 170,000 | +28.8% | 0.36% | +88.1% |
| Q1 2021 | $5,544,000 | +46.4% | 132,000 | +144.4% | 0.19% | +13.5% |
| Q4 2020 | $3,786,000 | +285.5% | 54,000 | +54.3% | 0.17% | +314.6% |
| Q3 2020 | $982,000 | -5.1% | 35,000 | 0.0% | 0.04% | -28.1% |
| Q2 2020 | $1,035,000 | +49.1% | 35,000 | 0.0% | 0.06% | +14.0% |
| Q1 2020 | $694,000 | -8.1% | 35,000 | +37.3% | 0.05% | +19.0% |
| Q4 2019 | $755,000 | +30.2% | 25,500 | 0.0% | 0.04% | +23.5% |
| Q3 2019 | $580,000 | +123.1% | 25,500 | +142.9% | 0.03% | +126.7% |
| Q2 2019 | $260,000 | – | 10,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |